Related Experiment Videos
[Alpha-fetoprotein and cystic fibrosis (author's transl)]
Klinische Wochenschrift
|April 15, 1976
Insights
Serum alpha-fetoprotein (AFP) levels were previously suggested to identify cystic fibrosis (CF) carriers. However, this study could not confirm elevated AFP levels in CF patients or their families.
Area of Science:
- Biochemistry
- Genetics
- Medical Diagnostics
Context:
- Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
- Previous research suggested elevated serum alpha-fetoprotein (AFP) in CF patients and carriers.
- A potential diagnostic marker for heterozygote carriers of the CF gene was proposed.
Purpose:
- To investigate the reliability of serum alpha-fetoprotein (AFP) levels as a marker for cystic fibrosis (CF) heterozygote carriers.
- To validate previous findings suggesting a correlation between AFP levels and CF gene carriage.
Summary:
- This study aimed to replicate findings that indicated elevated serum AFP levels in individuals with cystic fibrosis (CF) and their relatives.
- Utilizing radioimmunoassay, the researchers were unable to confirm the previously reported association between AFP levels and CF gene carriage.
- The results challenge the utility of AFP determination for detecting heterozygote carriers of the CF gene.
Impact:
- Challenges the previously proposed method for identifying cystic fibrosis carriers using AFP levels.
- Suggests further research is needed to validate or refute the AFP-CF connection.
- Highlights the importance of independent verification of diagnostic markers in genetic diseases.
Abstract:
Recently significantly raised serum levels of alpha-fetoprotein (AFP) were demonstrated in patients with cystic fibrosis (CF) and in their parents and some siblings; thereupon the determination of AFP was recommended for detecting heterozygote carriers of the CF-gene. These results could not be confirmed by our own investigations also using a radioimmunassay.